Information Journal Paper
APA:
CopyEVANS, A., & RIVA, A.. (2008). PROGRAMMED DEATH 1 EXPRESSION DURING ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B: IMPACT OF HEPATITIS B E-ANTIGEN SEROCONVERSION. HEPATOLOGY, 48(-), 759-769. SID. https://sid.ir/paper/635438/en
Vancouver:
CopyEVANS A., RIVA A.. PROGRAMMED DEATH 1 EXPRESSION DURING ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B: IMPACT OF HEPATITIS B E-ANTIGEN SEROCONVERSION. HEPATOLOGY[Internet]. 2008;48(-):759-769. Available from: https://sid.ir/paper/635438/en
IEEE:
CopyA. EVANS, and A. RIVA, “PROGRAMMED DEATH 1 EXPRESSION DURING ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B: IMPACT OF HEPATITIS B E-ANTIGEN SEROCONVERSION,” HEPATOLOGY, vol. 48, no. -, pp. 759–769, 2008, [Online]. Available: https://sid.ir/paper/635438/en